lauralea

Pull Back (Bottom) Fishing

NYSE:FMS   Fresenius Medical Care AG
This is a stock in healthcare and is in the dialysis field. It appears they missed earnings or gave grim guidance. Dialysis is grim, take my word for it )o:

Located in Germany but the clinics are in the US, and not a lot of competition. DVA is one that I know of.

Extremely oversold..

There has been extreme selling pressure indicated by being below the bollinger bands set at an 80 MA verses a 20 and 3 standard deviation verses 2. When there are no sellers left, which appears to be getting close, chances are, this will move up.

Bollinger bands are great and I do not think I could chart without them on TOS . Lots do not like the bands, we are all different. They move with price and get wide when volatility occurs and narrow when price is gonna pop one way or the other. The bands tell a lot about what is going on.


Gappy chart and I am not sure it is finished pulling back. If anyone is in the healthcare field, then we know dialysis is not going away, unfortunately.
Not a recommendation..just an observation.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides pharmacy services, vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2019, it operated 3,994 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.